Catalyst Wire Dossier Catalyst Wire Dossier

Removab

catumaxomab · Fresenius Biotech
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Removab, covering 2006-11-08 to 2017-07-12. Get the full timeline:

Most recent: EMA Withdrawn: Removab (catumaxomab) — Neovii Biotech GmbH

See pricing